|
Volumn 28, Issue 1, 1996, Pages 484-485
|
Molecular activation markers in rejection diagnosis
a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
CD31 ANTIGEN;
CD69 ANTIGEN;
HLA ANTIGEN CLASS 2;
INTERCELLULAR ADHESION MOLECULE 1;
INTERLEUKIN 2 RECEPTOR;
VASCULAR CELL ADHESION MOLECULE 1;
ANTIGEN DETECTION;
CONFERENCE PAPER;
GRAFT REJECTION;
HISTOPATHOLOGY;
HUMAN;
HUMAN CELL;
IMMUNOMODULATION;
KIDNEY GRAFT;
LYMPHOCYTE ACTIVATION;
MOLECULAR MODEL;
PRIORITY JOURNAL;
ACUTE DISEASE;
ANTIGENS, CD;
ANTIGENS, CD31;
ANTIGENS, DIFFERENTIATION, MYELOMONOCYTIC;
ANTIGENS, DIFFERENTIATION, T-LYMPHOCYTE;
BIOLOGICAL MARKERS;
CELL ADHESION MOLECULES;
E-SELECTIN;
GRAFT REJECTION;
HISTOCOMPATIBILITY ANTIGENS CLASS II;
HUMANS;
INTERCELLULAR ADHESION MOLECULE-1;
KIDNEY TRANSPLANTATION;
LYMPHOCYTE ACTIVATION;
RECEPTORS, INTERLEUKIN-2;
VASCULAR CELL ADHESION MOLECULE-1;
|
EID: 0029863910
PISSN: 00411345
EISSN: None
Source Type: Journal
DOI: None Document Type: Conference Paper |
Times cited : (1)
|
References (0)
|